Drug Side Effects
Search
BLADDER TRANSITIONAL CELL CARCINOMA STAGE II
BLADDER TRANSITIONAL CELL CARCINOMA STAGE II
was reported 46 times
These drug classes are most commonly taken by patients reporting BLADDER TRANSITIONAL CELL CARCINOMA STAGE II:
#
Drug
Count
0
Nonsteroidal Anti-inflammatory Drug [EPC]
9
1
Tumor Necrosis Factor Blocker [EPC]
9
2
Platelet Aggregation Inhibitor [EPC]
8
3
Xanthine Oxidase Inhibitor [EPC]
6
4
Folate Analog Metabolic Inhibitor [EPC]
5
5
Peroxisome Proliferator Receptor alpha Agonist [EPC]
4
6
Angiotensin 2 Receptor Blocker [EPC]
3
7
Calcium [EPC]
3
8
Insulin Analog [EPC]
3
9
Sulfonylurea [EPC]
3
10
Antirheumatic Agent [EPC]
2
11
CD20-directed Cytolytic Antibody [EPC]
2
12
Corticosteroid [EPC]
2
13
GLP-1 Receptor Agonist [EPC]
2
14
HMG-CoA Reductase Inhibitor [EPC]
2
15
Interleukin-17A Antagonist [EPC]
2
16
Loop Diuretic [EPC]
2
17
Nitrate Vasodilator [EPC]
2
18
Thalidomide Analog [EPC]
2
19
Alkylating Drug [EPC]
1
20
Amino Acid [EPC]
1
21
Antimycobacterial [EPC]
1
22
Benzodiazepine [EPC]
1
23
Factor Xa Inhibitor [EPC]
1
24
GLP-2 Analog [EPC]
1
25
Integrin Receptor Antagonist [EPC]
1
26
Lipid Emulsion [EPC]
1
27
Proton Pump Inhibitor [EPC]
1
28
Thiazide Diuretic [EPC]
1
29
beta-Adrenergic Blocker [EPC]
1